Translational Stroke Research
From Target Selection to Clinical Trials
John H Zhang editor Paul A Lapchak editor
Format:Paperback
Publisher:Springer-Verlag New York Inc.
Published:23rd Aug '16
Should be back in stock very soon
This volume sets a basis for effective translational research. Authored by experts in the field of translational stroke research, each chapter specifically addresses one or more components of preclinical stroke research. The emphasis is placed on target identification and drug development using state-of-the-art in vitro and in vivo assays, in combination with in vitro toxicology assays, AMDE and clinical design.
From the reviews:
“This book is an excellent review of cerebral hemorrhage, ischemia, and hypoxia as it involves pathology, pathophysiology, and cellular tolerance. It will appeal to a wide variety of investigators in stroke, neurology, and neurosurgery research. I highly recommend it in Neurology Research.” (Joseph J. Grenier, Amazon.com, February, 2014)
“In Translational Stroke Research, Lapchak and Zhang have gathered an impressive, and very large, assortment of clinicians and researchers from around the world to offer reports of their studies, new ideas … and directions for future research based mainly on pleotropic and combined therapies. … The authors are to be congratulated on a great effort in furthering the available information and pitfalls in this field and pointing researchers and practitioners in a clinically significant direction. … It makes for fascinating reading!” (Elizabeth A. M. Frost, Journal of Neurosurgical Anesthesiology, Vol. 24 (4), October, 2ISBN: 9781493941384
Dimensions: unknown
Weight: unknown
923 pages
Softcover reprint of the original 1st ed. 2012